Results 11 to 20 of about 121,410 (303)

Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men [PDF]

, 2013
<p>Recombinant human erythropoietin (rHuEpo) increases haemoglobin mass (Hbmass) and maximal oxygen uptake (v˙ O2 max).</p> <p>Purpose: This study defined the time course of changes in Hbmass, v˙ O2 max as well as running time trial ...
A Lucia, AJ Brien, B Berglund, BD Levine, C Ahlgrim, C Lundby, C Lundby, C Lundby, CC Chang, CP Alfrey, D Boning, Diresibachew H. Wondimu, DL Costill, DP Wilkerson, Elias T. Zambidis, Evangelia Daskalaki, G Banfi, G Ninot, G Russell, GP Millet, H Ehrenreich, I Mujika, JD Belcher, JJ Thomsen, JM Kirkeberg, John D. McClure, Jérôme Durussel, K Heinicke, K Miskowiak, KI Birkeland, L Rice, L Rice, M Audran, M Brines, Martin Anderson, Neal Padmanabhan, NV Olsen, P Connes, P Rasmussen, PB Laursen, R Parisotto, Rajan K. Patel, RJ Shephard, RR Engel, RS Franco, SW Ryter, TD Noakes, TD Noakes, Tushar Chatterji, W Jelkmann, W Schmidt, Yannis P. Pitsiladis   +51 more
core   +7 more sources

Evaluation of the stability of human erythropoietin in samples for radioimmunoassay [PDF]

, 1988
Radioimmunoassays for erythropoietin are limited so far to a few specialized laboratories and this requires transport and storage of samples. We therefore tested the stability of immunoreactive erythropoietin in serum and plasma samples obtained from a ...
Bauer, Christian, Eckardt, Kai-Uwe, Hirth, P., Kurtz, Armin, Scigalla, P., Wieczorek, L.   +5 more
core   +1 more source

Bench-to-bedside review: Erythropoietin and its derivatives as therapies in critical care [PDF]

, 2012
Author can archive publisher's pdf. Free via Creative Commons: CC-BENCHTOBEDSIDE-2.0.
Nandra, KK, Patel, NSA, Thiemermann, C
core   +1 more source

Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure [PDF]

, 1993
The single-dose pharmacokinetics of recombinant human erythropoietin (rHuEPO) given SC was investigated in 20 patients aged 7-20 years at different stages of chronic renal failure.
Braun, A., Ding, R., Fies, T., Kurtz, Armin, Schärer, K., Seidel, C.   +5 more
core   +1 more source

Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure [PDF]

, 2016
Aims Although previous reports suggest that an elevated endogenous erythropoietin (EPO) level is associated with worse clinical outcomes in chronic heart failure (HF) patients, the prognostic implication of EPO in patients with acute decompensated HF ...
Anand, Anker, Asaumi, Beguin, Belonje, Belonje, Belonje, Breunig, Cazzola, Diskin, Ezekowitz, Feldschuh, George, Ghali, Grote Beverborg, Levy, Lipsic, Massie, McKee, Meer, Meer, Meer, Silverberg, Smilde, Swedberg, Takei, Teerlink, Westenbrink   +27 more
core   +1 more source

Macrophages as novel target cells for erythropoietin

Haematologica, 2010
Background Our original demonstration of immunomodulatory effects of erythropoietin in multiple myeloma led us to the search for the cells in the immune system that are direct targets for erythropoietin.
Lilach Lifshitz, Galit Tabak, Max Gassmann, Moshe Mittelman, Drorit Neumann   +4 more
doaj   +1 more source

Low oxygen tension primes aortic endothelial cells to the reparative effect of tissue-protective cytokines [PDF]

, 2015
Erythropoietin (EPO) has both erythropoietic and tissue-protective properties. The EPO analogues carbamylated EPO (CEPO) and pyroglutamate helix B surface peptide (pHBSP) lack the erythropoietic activity of EPO but retain the tissue-protective properties
A Anagnostou, A Phrommintikul, AW Clowes, B Xu, BB Beleslin-Cokic, BB Beleslin-Cokic, BBB Cokic, C Ferri, CI Guenter, CL Bennett, CT Noguchi, DA Padgett, E Gammella, E Moore, F Dumont, F Fiordaliso, F Marzo, F Sanchis-Gomar, FH Bahlmann, G Grasso, GL Semenza, Gordon Ferns, H Ueba, HE Broxmeyer, I Cervellini, J Varani, JP Cooke, K-H Su, KJ Zwezdaryk, L Sautina, L Velly, L Wang, Lamia Heikal, LF Congote, M Bernaudin, M Brines, M Brines, M Brines, M Brines, M Leist, M Mengozzi, M Mengozzi, M Nangaku, Manuela Mengozzi, ML Trincavelli, N Liu, OM Martinez-Estrada, Pietro Ghezzi, RD Lester, S Bohr, S Bohr, SS Watowich, T Nakao, T Wun, TR Coleman, W Jelkmann, Z Erbayraktar, ZZ Chong   +57 more
core   +1 more source

Neuronal damage after moderate hypoxia and erythropoietin

Neurobiology of Disease, 2005
Both mild hypoxia and exogenous erythropoietin may protect the brain against subsequent severe hypoxia, and the conditioning effect of transient hypoxia is partly mediated by hypoxia-induced endogenous erythropoietin.
Astrid Weber, Mark Dzietko, Monika Berns, Ursula Felderhoff-Mueser, Uwe Heinemann, Rolf F. Maier, Michael Obladen, Chrissanthi Ikonomidou, Christoph Bührer   +8 more
doaj   +1 more source

Erythropoietin production by fetal mouse liver cells in response to hypoxia and adenylate cyclase stimulation [PDF]

, 1986
This study was done to investigate aspects of control of extrarenal erythropoietin (Ep) production. To this end we studied the effects of three stimuli of renal Ep production in the adult, i.e.
Bauer, Christian, Jelkmann, W., Kurtz, Armin, Malmström, K., Pfuhl, A.   +4 more
core   +1 more source

Erythropoietin [PDF]

Cold Spring Harbor Perspectives in Medicine, 2013
During the past century, few proteins have matched erythropoietin (Epo) in capturing the imagination of physiologists, molecular biologists, and, more recently, physicians and patients. Its appeal rests on its commanding role as the premier erythroid cytokine, the elegant mechanism underlying the regulation of its gene, and its remarkable impact as a ...
openaire   +2 more sources